Hideo Tsutsumi

This inventor holds 25 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh, Wakunaga Pharmaceutical Co., Ltd.. Active years: 1985-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideo Tsutsumi. Retrieved from https://idiyas.com/inventor/hideo-tsutsumi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 1)

% Patents Active = 92.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2

Average Co-Inventor Count = 4.7

ph-index = 10

Forward Citations = 250(Granted Patents)

Location History:

Yuhigaoka, JP (1987)
Toyonaka, JP (1985 - 2001)
Osaka, JP (1991 - 2011)

Company Filing History:

21 out of 940

Fujisawa Pharmaceutical Company, Ltd.

Wakunaga Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 1985-2011

Loading Chart...

Areas of Expertise:

Carbapenem Compounds

Aminoglycoside Derivatives

Pyrazine Derivatives

Hetero Compounds

Histone Deacetylase Inhibitors

Sulphonyl Compounds

Tricyclic Pyrido Compounds

Combinatorial Synthesis

Antimicrobial Agents

Pharmaceutical Use

Synthetic Processes

3-Pyrrolidinylthio Compounds

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7951825 - Hetero compound (2011-05-31),

2. 7750155 - Pyrazinyl hydroxyacrylamide compounds having an inhibitory effect on the activity of histone deacetylase (2010-07-06),

3. 7678820 - Hetero compound (2010-03-16),

4. 7265120 - Pyrazine derivatives and pharmaceutical use thereof (2007-09-04),

5. 6225480 - Sulphonyl compounds for use as linkers in solid phase and combinatorial synthesis (2001-05-01),

6. 5608056 - Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents (1997-03-04),

7. 5420122 - 3-pyrrolidinylthio-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylic acid (1995-05-30),

8. 5359066 - Certain tricyclic pyrido[3,2,1-ij]cinnoline-8-carboxylates, useful as (1994-10-25),

9. 5306816 - Processes for preparing carbapenem derivatives (1994-04-26),

10. 5286721 - 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds (1994-02-15),

11. 5215983 - Carbapenem compounds (1993-06-01),

12. 5202437 - 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid (1993-04-13),

13. 5138064 - 3-Pyrrolidinylthio-1-azabicyclo-[3.2.0]hept-2-ene-2-carboxylic acid (1992-08-11),

14. 5102877 - 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds (1992-04-07),

15. 5061804 - 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid (1991-10-29),

Title: The Innovations of Hideo Tsutsumi

Introduction

Hideo Tsutsumi, a prominent inventor based in Toyonaka, Japan, has made significant contributions to the field of pharmaceuticals and biotechnology. With a remarkable portfolio of 25 patents, his work primarily focuses on developing compounds that improve organ transplantation outcomes and treat various autoimmune diseases.

Latest Patents

Among his latest innovations, Tsutsumi has introduced compounds that serve as active ingredients in preventing and treating rejection in organ transplantation. His hetero compounds exhibit excellent S1P agonist activity, making them invaluable in addressing autoimmune diseases such as graft-versus-host disease, rheumatic arthritis, multiple sclerosis, and more. Additionally, he has developed pyrazinyl hydroxyacrylamide compounds, which function as histone deacetylase (HDAC) inhibitors. These compounds provide a promising approach for the therapeutic treatment and prevention of HDAC-related diseases.

Career Highlights

Hideo Tsutsumi has had a distinguished career with major pharmaceutical companies. He has worked with Fujisawa Pharmaceutical Company, Ltd., where he honed his expertise in drug development. Later, he contributed to Astellas Pharma GmbH, further advancing his innovative research and patent portfolio.

Collaborations

Throughout his career, Tsutsumi has collaborated with notable colleagues, including Masayoshi Murata and Keiji Matsuda. These partnerships have been instrumental in driving his research forward and enhancing the impact of his inventions in the pharmaceutical industry.

Conclusion

Hideo Tsutsumi stands out as a leading inventor whose patents reflect his dedication to improving health outcomes through innovative research. His work continues to influence the treatment of complex diseases, demonstrating the vital role that inventors play in advancing medical science.

Profile summary based on public USPTO records.